Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …

Background Non-AIDS-defining cancers (NADCs) are now becoming a rising cause of
morbidity among people living with HIV (PLHIV) in the highly active antiretroviral therapy …

The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging,
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …

Background People with HIV have higher risk of hepatocellular carcinoma than the general
population, partly because of higher prevalence of coinfection with hepatitis B virus (HBV) or …

Hepatocellular carcinoma is a leading public health concern in sub-Saharan Africa, and it is
most prevalent in young adults (median 45 years [IQR 35–57]). Overall, outcomes are poor …

Background and aims Data are needed to inform hepatitis B virus (HBV) testing and
treatment policies in Ghana to make progress towards achieving the 2030 WHO elimination …

HIV-HBV coinfected patients have higher rates of liver-related morbidity, hospitalizations,
and mortality compared to HBV or HIV mono-infected ones. Clinical studies have shown an …

Liver-related diseases are associated with the high levels of morbidity and mortality in
people living with HIV. Between 13% and 18% of all-cause mortality in HIV-infected patients …

Background Cancer is the leading cause of mortality in people living with HIV (PWH) and is
expected to account for a growing fraction of deaths as PWH age. Methods In this literature …

Despite substantial advances in the field, liver disease morbidity and mortality remain
serious issues among people with HIV. The causes of liver disease are often multifactorial …